Mar 23, 10 | Posted by: Bayshore Pediatrics

Rotarix vaccine in the news

The rotavirus vaccine brand name Rotarix has recently been in the news.  As of Monday, March 22nd, the FDA and CDC suspended the sale and use of Rotarix, a vaccine manufactured by Glaxo-Smith Kline.    The FDA has learned that DNA from porcine circovirus type 1 (PCV1) is present in Rotarix.  There is no evidence at this time that this finding poses a safety risk.  While the agency is learning more about the situation, FDA is recommending that clinicians and public health professionals in the United States temporarily suspend the use of Rotarix.  

Bayshore Pediatrics does not use Rotarix as the rotavirus vaccine given.  Bayshore Pediatrics uses Rotateq manufactured by Merck.  The majority of children in the United States vaccinated against rotavirus received RotaTeq.  RotaTeq is made using different materials from Rotarix.  FDA has no evidence that DNA from PCV1 is present in RotaTeq.

To find out more information, the FDA is providing updates as the investigation progresses.  Go to FDA Rotarix Updates for more information.

No Comments »